All Stories

  1. Neurobiological support to the diagnosis of ADHD in stimulant-naïve adults: pattern recognition analyses of MRI data

    Article • Acta Psychiatrica Scandinavica, October 2017, Wiley

    Dr Mario R Louza, Dr Mauricio Henriques Serpa

  2. Psychodynamic aspects of adults with ADHD

    Article • Journal of Attention Disorders, July 2016, SAGE Publications

    Dr Mario R Louza, Vanessa V Silva

  3. High IQ May “Mask” the Diagnosis of ADHD by Compensating for Deficits in Executive Functions in Treatment-Naïve Adults With ADHD

    Article • Journal of Attention Disorders, July 2016, SAGE Publications

    Dr Mario R Louza, Master Carmen S Miguel, Dr Mauricio Henriques Serpa

  4. Neurofibromatosis type 1 and attention deficit hyperactivity disorder: a case study and literature review

    Article • March 2015, Taylor & Francis

    Dr Mario R Louza, Master Carmen S Miguel

  5. Distinctive types of executive dysfunction on cocaine dependence and ADHD compared to healthy controls

    Article • Drug and Alcohol Dependence, January 2015, Elsevier

    Dr Andre Malbergier, Dr Mario R Louza

  6. Multimodal Magnetic Resonance Imaging Study of Treatment-Naïve Adults with Attention-Deficit/Hyperactivity Disorder

    Article • PLoS ONE, October 2014, PLOS

    Dr Mario R Louza, Dr Mauricio Henriques Serpa

  7. Influence of stimulant and non-stimulant drug treatment on driving performance in patients with attention deficit hyperactivity disorder: A systematic review

    Article • European Neuropsychopharmacology, September 2014, Elsevier

    Dr Mario R Louza

  8. Fractionating Executive Functions of Adults With ADHD

    Article • Journal of Attention Disorders, August 2014, SAGE Publications

    Dr Mario R Louza

  9. Poster #T53 THE KUMON METHOD FOR COGNITIVE REMEDIATION OF INDIVIDUALS WITH SCHIZOPHRENIA: A RANDOMIZED PLACEBO-CONTROLLED TRIAL

    Article • Schizophrenia Research, April 2014, Elsevier

    Dr Mario R Louza

  10. Poster #M4 TREATMENT OF CLOZAPINE-INDUCED HYPERSALIVATION WITH AMISULPRIDE: A SYSTEMATIC REVIEW

    Article • Schizophrenia Research, April 2014, Elsevier

    Dr Mario R Louza

  11. Health-related quality of life in adults with attention-deficit and hyperactivity disorder

    Article • Medical Express, January 2014, GN1 Genesis Network

    Dr Mario R Louza

  12. Switching from oral risperidone to flexibly dosed oral paliperidone extended-release: core symptoms, satisfaction, and quality of life in patients with stable but symptomatic schizophrenia: the RISPALI study

    Article • Current Medical Research and Opinion, December 2013, Informa Healthcare

    Dr Mario R Louza

  13. Weight gain, metabolic disturbances, and physical health care in a Brazilian sample of outpatients with schizophrenia

    Article • Neuropsychiatric Disease and Treatment, January 2013, Taylor & Francis

    Dr Mario R Louza

  14. Poster #156 NEUROPSYCHOLOGICAL PERFORMANCE OF INDIVIDUALS AT ULTRA HIGH RISK OR FIRST EPISODE PSYCHOSIS

    Article • Schizophrenia Research, April 2012, Elsevier

    Dr Mario R Louza

  15. A Multicenter, Open-Label Trial to Evaluate the Quality of Life in Adults With ADHD Treated With Long-Acting Methylphenidate (OROS MPH)

    Article • Journal of Attention Disorders, February 2012, SAGE Publications

    Dr Mario R Louza

  16. Is psychodynamic psychotherapy an effective intervention for individuals at ultra-high risk (UHR) of psychosis?: a case report

    Article • Jornal Brasileiro de Psiquiatria, January 2012, FapUNIFESP (SciELO)

    Dr Mario R Louza

  17. Personal and Social Performance (PSP) scale for patients with schizophrenia: translation to Portuguese, cross-cultural adaptation and interrater reliability

    Article • Jornal Brasileiro de Psiquiatria, January 2012, FapUNIFESP (SciELO)

    Dr Mario R Louza

  18. Long-acting injectable risperidone in partially adherent and nonadherent patients with schizophrenia

    Article • Neuropsychiatric Disease and Treatment, June 2011, Taylor & Francis

    Dr Mario R Louza, Irismar Reis de Oliveira

  19. Clinical outcomes of long-acting injectable risperidone in patients with schizophrenia: six-month follow-up from the Electronic Schizophrenia Treatment Adherence Registry in Latin America

    Article • Neuropsychiatric Disease and Treatment, December 2010, Taylor & Francis

    Dr Mario R Louza

  20. Exploring the knowledge contained in neuroimages: Statistical discriminant analysis and automatic segmentation of the most significant changes

    Article • Artificial Intelligence in Medicine, June 2010, Elsevier

    Dr Mario R Louza

  21. Lack of Association Between a 3’UTR VNTR Polymorphism of Dopamine Transporter Gene (SLC6A3) and ADHD in a Brazilian Sample of Adult Patients

    Article • Journal of Attention Disorders, March 2010, SAGE Publications

    Dr Mario R Louza

  22. Association between a SLC6A3 intron 8 VNTR functional polymorphism and ADHD in a Brazilian sample of adult patients

    Article • Brazilian Journal of Psychiatry, December 2009, FapUNIFESP (SciELO)

    Dr Mario R Louza

  23. Insight, cognitive dysfunction and symptomatology in schizophrenia

    Article • European Archives of Psychiatry and Clinical Neuroscience, April 2008, Springer Science + Business Media

    Dr Mario R Louza

  24. 326 – Brazilian open-label switch study in noncompliant schizophrenic patients from oral antipsychotics to long-acting risperidone: A six-month interim analysis of a 12-month, multicentric study

    Article • Schizophrenia Research, February 2008, Elsevier

    Dr Mario R Louza

  25. Letter to the Editor

    Article • Journal of Attention Disorders, May 2007, SAGE Publications

    Dr Mario R Louza

  26. Alterações cognitivas na esquizofrenia: conseqüências funcionais e abordagens terapêuticas

    Article • Archives of Clinical Psychiatry (São Paulo), January 2007, FapUNIFESP (SciELO)

    Dr Mario R Louza

  27. Detecção precoce: é possível prevenir a esquizofrenia?

    Article • Archives of Clinical Psychiatry (São Paulo), January 2007, FapUNIFESP (SciELO)

    Dr Mario R Louza

  28. Novos antipsicóticos para o tratamento da esquizofrenia

    Article • Archives of Clinical Psychiatry (São Paulo), January 2007, FapUNIFESP (SciELO)

    Dr Mario R Louza

  29. Questões atuais no tratamento farmacológico do TDAH em adultos com metilfenidato

    Article • Jornal Brasileiro de Psiquiatria, January 2007, FapUNIFESP (SciELO)

    Dr Mario R Louza

  30. Insight and regional brain volumes in schizophrenia

    Article • European Archives of Psychiatry and Clinical Neuroscience, September 2006, Springer Science + Business Media

    Dr Mario R Louza

  31. Attention deficit hyperactivity disorder (ADHD) in adults: social-demographic profile from a university hospital ADHD outpatient unit in São Paulo, Brazil

    Article • Arquivos de Neuro-Psiquiatria, September 2006, FapUNIFESP (SciELO)

    Dr Mario R Louza

  32. Oestrogen-A Protective Factor in Schizophrenia?

    Article • Current Psychiatry Reviews, August 2006, Bentham Science Publishers

    Professor Anita Riecher-Rössler, Dr Mario R Louza

  33. Painel brasileiro de especialistas sobre diagnóstico do transtorno de déficit de atenção/hiperatividade (TDAH) em adultos

    Article • Revista de Psiquiatria do Rio Grande do Sul, April 2006, FapUNIFESP (SciELO)

    Dr Mario R Louza

  34. Adaptação transcultural para o português da escala Adult Self-Report Scale para avaliação do transtorno de déficit de atenção/hiperatividade (TDAH) em adultos

    Article • Archives of Clinical Psychiatry (São Paulo), January 2006, FapUNIFESP (SciELO)

    Dr Mario R Louza

  35. Conjugated estrogens as adjuvant therapy in the treatment of acute schizophrenia: a double-blind study

    Article • Schizophrenia Research, February 2004, Elsevier

    Dr Mario R Louza

  36. Schizophrenia and use of antipsychotics: Prevalence of overweight, lipid abnormalities and diabetes mellitus

    Article • Schizophrenia Research, March 2003, Elsevier

    Dr Mario R Louza

  37. Willy Mayer-Gross (1889-1961)

    Article • Archives of Clinical Psychiatry (São Paulo), January 2003, FapUNIFESP (SciELO)

    Dr Mario R Louza

  38. Os antipsicóticos de nova geração e suas meta-análises

    Article • Archives of Clinical Psychiatry (São Paulo), January 2003, FapUNIFESP (SciELO)

    Dr Mario R Louza

  39. Demência com corpúsculos de Lewy: uma entidade distinta com tratamento específico?

    Article • Brazilian Journal of Psychiatry, September 2002, FapUNIFESP (SciELO)

    Dr Mario R Louza

  40. Do Religious Mediumship Dissociative Experiences Conform to the Sociocognitive Theory of Dissociation?

    Article • Journal of Trauma & Dissociation, January 2002, Taylor & Francis

    Dr Mario R Louza

  41. Attention deficit hiperactivity disorder (ADHD) in adults: Demographic caracteristics, comorbidity and treatment

    Article • European Neuropsychopharmacology, January 2001, Elsevier

    Dr Mario R Louza

  42. Relação entre data de admissão hospitalar e período do ciclo menstrual de mulheres com diagnóstico de esquizofrenia

    Article • Brazilian Journal of Psychiatry, June 2000, FapUNIFESP (SciELO)

    Dr Mario R Louza

  43. Manejo clínico do primeiro episódio psicótico

    Article • Brazilian Journal of Psychiatry, May 2000, FapUNIFESP (SciELO)

    Dr Mario R Louza

  44. Clozapine efficacy in tardive dyskinesia — 3 years' follow-up

    Article • Schizophrenia Research, January 2000, Elsevier

    Dr Mario R Louza

  45. Dissociação e transtornos dissociativos: modelos teóricos

    Article • Brazilian Journal of Psychiatry, December 1999, FapUNIFESP (SciELO)

    Dr Mario R Louza

  46. Treatment of severe Tardive Dyskinesia (TD) in refractory schizophrenics with clozapine

    Article • Schizophrenia Research, January 1997, Elsevier

    Dr Mario R Louza

  47. Higher morbidity risk for schizophrenia in males: Fact or fiction?

    Article • Comprehensive Psychiatry, January 1994, Elsevier

    Professor Anita Riecher-Rössler, Dr Mario R Louza

  48. BRAINSTEM AUDITORY EVOKED POTENTIALS (BAEP) IN PSYCHIATRIC INPATIENTS.

    Article • Clinical Neuropharmacology, January 1992, Wolters Kluwer Health

    Dr Mario R Louza

  49. Functional relationship among brain regions in schizophrenia: evaluation with pearson's product-moment correlation between event-related potentials (ERPs)

    Article • Electroencephalography and Clinical Neurophysiology, January 1990, Elsevier

    Dr Mario R Louza

  50. Normative Aspekte der somatosensorisch evozierten P300-Komponente

    Article • Klinische Neurophysiologie, June 1989, Thieme Publishing Group

    Dr Mario R Louza

  51. Haloperidol Plasma Level after a Test Dose as Predictor for the Clinical Response to Treatment in Acute Schizophrenic Patients

    Article • Pharmacopsychiatry, September 1988, Thieme Publishing Group

    Dr Mario R Louza

  52. A Region-Based Ontology of the Brain Ventricular System and Its Relation to Schizophrenia

    Article • IGI Global

    Dr Mario R Louza